伊利股份2020年度暨2021年第一季度業績電話會議邀請 (Yili FY 2020 & Q1 2021 Results Call Invitation)
各位尊敬的投資者:
公司將于2021年4月29日(周四)上午9:00-10:30舉行伊利股份2020年度暨2021年第一季度業績電話會,公司董事長兼總裁潘剛先生、董事會秘書邱向敏先生、投資者關系部總經理趙琳女士將出席會議,誠邀各位投資者參加!
本次業績電話說明會將采用網上預報名的方式進行,提前提供正確號碼進行報名注冊將有助于您快速撥入會議,減少等待時間。請您提前登錄http://register.yili.com,提交您的報名信息,進行預報名。您也可以在以上鏈接中填寫您關注的問題,公司將在業績說明會上選擇投資者普遍關注的問題進行回答。
會議時間:
2021年4月29日(周四)上午9:00-10:30 (北京時間)
會議語言:中文
會議撥入號碼:
中國內地:4008 063 263/023-6362 3333
香港:+852-3018 6949/800 931018
臺灣: +886-(0)2-2656 3394
新加坡: +65-6407 5649
美國:+1-516-226 8028/1800 3876 988
英國:+44-20-7097 0018/0800 0291098
國際:+86-23-6273 7100
參會人密碼:203229818
為避免電話會議當天同時撥入導致線路擁擠,請大家提前5-10分鐘撥入會場等待。
如有任何疑問,請聯系0471-3350092或info@yili.com。
內蒙古伊利實業集團股份有限公司
Dear Investors,
Yili will hold a conference call on Thursday, April 29, 2021 at 9:00-10:30 a.m. Beijing Time to review FY 2020 & Q1 2021 Results. Mr. Pan Gang, Chairman and CEO, Mr. Qiu Xiangmin, Secretary to the Board and Ms. Zhao Lin, General Manager of IR, will participate in the conference call and all investors are sincerely invited to participate.
Please be noted that this conference call requires online registration, registration in advance will ensure your smooth access to the conference call and reduce waiting time. Please log in to http://register.yili.com to register. You are also encouraged to fill in the questions you are interested in through the above link, and we will answer the most frequently asked questions on the Q&A session.
Date and Time:
Thursday, April 29, 2021 9:00-10:30 a.m. Beijing Time
Language:
Mandarin
Dial-in Numbers:
China (Mainland):4008 063 263 / 023-6362 3333
Hong Kong: +852-3018 6949/800 931018
Taiwan: +886-(0)2-2656 3394
Singapore: +65-6407 5649
US: +1-516-226 8028/1800 3876 988
UK: +44-20-7097 0018/0800 0291098
International: +86-23-6273 7100
Passcode: 203229818
Callers are encouraged to dial in 5-10 minutes in advance to ensure you are connected prior to the beginning of the call.
For additional information, please contact us at 0471-3350092 or info@yili.com.
Inner Mongolia Yili Industrial Group Co.,Ltd.